
TCT 2024: Vivasure Medical to Present US Pivotal Data for PerQseal® Elite
Vivasure Medical®, a leader in fully absorbable technology for percutaneous vessel closure, will reveal the findings from its U.S. PATCH Study at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference in…












